← Leaderboards
Alberto Gandini
Accel Diagnostics, Llc
$4,704,957
Attributed
$4,967,161
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $963.6K · FY2012–24$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,967,161 · 9
By mechanism
R44$2,643,679 · 2
R43$1,383,503 · 5
N44$727,427 · 1
N01$212,552 · 1
Top collaborators
- James F. Antaki2 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPre-ClinicalTechnologyBloodPrototypeDevicesValidationMonitorFingersUniversitiesLegal PatentPoint Of CareCostDiagnosisSamplingPhysiciansDiagnosticScale UpBlood TestsBaseAntibodiesTranslatingFundingSample Size
Grant awards (15)
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.$398,753
R44 · FY2024 · AI · contact PI
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.$97,316
R44 · FY2023 · AI · contact PI
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.$963,581
R44 · FY2022 · AI · contact PI
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.$240,405
R44 · FY2021 · AI · contact PI
A rapid blood test to aid the triage of patients affected by head injuries.$223,966
R43 · FY2020 · NS · contact PI
SBIR Topic 097, Phase II - Early Detection and Monitoring of Cardiac Injury Due to Cardiotoxicity$727,427
N44 · FY2019 · HL · contact PI
A Rapid Non-Invasive Device for Monitoring Preeclampsia in High Risk Pregnancy$215,450
R43 · FY2019 · HD · contact PI
A disposable assay for the monitoring of heart failure in the home setting.$331,659
R44 · FY2018 · HL · contact PI
A disposable assay for the monitoring of heart failure in the home setting.$611,965
R44 · FY2017 · HL · contact PI
I-Corps Program for A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood.$49,046
R43 · FY2017 · AI · contact PI
SBIR Topic 97 - Minimally Invasive Test for Chemotherapy-induced Cardiotoxicity - Phase I$212,552
N01 · FY2016 · HL · contact PI
A rapid instrument-free diagnostic assay for the early detection and quantification of sepsis biomarkers in blood$145,499
R43 · FY2016 · AI · contact PI
A disposable assay for the monitoring of heart failure in the home setting$225,133
R43 · FY2015 · HL · contact PI
Blood Filtration System for the Treatment of Severe Malaria Patients$168,846
R43 · FY2013 · HL · contact PI
Blood Filtration System for the Treatment of Severe Malaria Patients$355,563
R43 · FY2012 · HL · contact PI